MediPal Holdings Corporation
MAHLY
Price:
$16.64
Market Cap:
$532.73B
Medipal Holdings Corporation, a Tokyo-based Japanese company founded in 1898, primarily operates as a wholesaler of prescription pharmaceuticals throughout Japan. Beyond its core drug distribution, the company also sources and supplies a comprehensive range of healthcare-related products, including medical equipment, materials, and clinical diagnostic reagents, used from the earliest pre-symptomatic stages through treatment. Its services extend to offering post-marketing surveillance (PMS) to pharmaceutical manufacturers and investing in the development of orphan drugs. Medipal's extensive wholesale activities also encompass a diverse array of other goods, such as cosmetics, daily necessitie...[Read more]
Industry
Medical - Distribution
IPO Date
2009-10-06
Stock Exchange
OTC
Ticker
MAHLY
PE Ratio
[12.90]
ROE
[6.72%]
Current Ratio
[1.28]
Dividend Yield
[2.54%]
Enterprise Value
[243.66B]
Dividend History
The ROE as of June 2026 (TTM) for MediPal Holdings Corporation (MAHLY) is 6.72%
According to MediPal Holdings Corporation’s latest financial reports and current stock price. The company's current ROE is 6.72%. This represents a change of 298.85% compared to the average of 1.68% of the last 4 quarters.
MediPal Holdings Corporation (MAHLY) Historical ROE (quarterly & annually)
How has MAHLY ROE performed in the past?
The mean historical ROE of MediPal Holdings Corporation over the last ten years is 6.52%. The current 6.72% ROE has changed 2.97% with respect to the historical average. Over the past ten years (40 quarters), MAHLY's ROE was at its highest in in the December 2017 quarter at 2.46%. The ROE was at its lowest in in the March 2022 quarter at 0.11%.
Average
6.52%
Median
6.74%
Minimum
4.57%
Maximum
7.59%
MediPal Holdings Corporation (MAHLY) ROE by Quarter and Year
Discovering the peaks and valleys of MediPal Holdings Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 24.59%
Maximum Annual ROE = 7.59%
Minimum Annual Increase = -39.72%
Minimum Annual ROE = 4.57%
| Year | ROE | Change |
|---|---|---|
| 2026 | 6.52% | 0.32% |
| 2025 | 6.50% | -5.89% |
| 2024 | 6.91% | -0.06% |
| 2023 | 6.91% | 24.59% |
| 2022 | 5.55% | 21.28% |
| 2021 | 4.57% | -39.72% |
| 2020 | 7.59% | 9.75% |
| 2019 | 6.91% | -3.64% |
| 2018 | 7.18% | 9.23% |
| 2017 | 6.57% | -11.41% |
MediPal Holdings Corporation (MAHLY) Average ROE
How has MAHLY ROE performed in the past?
The current ROE of MediPal Holdings Corporation (MAHLY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
6.64%
5-year avg
6.48%
10-year avg
6.52%
MediPal Holdings Corporation (MAHLY) ROE vs. Peers
How is MAHLY’s ROE compared to its peers?
MediPal Holdings Corporation’s ROE is less than Shandong Weigao Group Medical Polymer Company Limited (6.69%), less than Alfresa Holdings Corporation (8.48%), less than Shandong Weigao Group Medical Polymer Company Limited (6.69%), less than Santen Pharmaceutical Co., Ltd. (13.15%), less than Sundrug Co.,Ltd. (11.29%), less than Gedeon Richter PLC (16.73%), less than The United Laboratories International Holdings Limited (12.65%), less than Ansell Limited (7.05%), less than Ansell Limited (7.05%), greater than Ryman Healthcare Limited (-4.17%),
| Company | ROE | Market cap |
|---|---|---|
| 6.69% | $1.79B | |
| 8.48% | $2.51B | |
| 6.69% | $1.91B | |
| 13.15% | $3.83B | |
| 11.29% | $3.30B | |
| 16.73% | $7.19B | |
| 12.65% | $2.45B | |
| 7.05% | $2.97B | |
| 7.05% | $2.77B | |
| -4.17% | $1.43B |
Build a custom stock screener for MediPal Holdings Corporation (MAHLY) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MediPal Holdings Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
MediPal Holdings Corporation (MAHLY) and other stocks custom spreadsheet templates
The easiest way to analyze a company like MediPal Holdings Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is MediPal Holdings Corporation's ROE?
How is the ROE calculated for MediPal Holdings Corporation (MAHLY)?
What is the highest ROE for MediPal Holdings Corporation (MAHLY)?
What is the 3-year average ROE for MediPal Holdings Corporation (MAHLY)?
What is the 5-year average ROE for MediPal Holdings Corporation (MAHLY)?
How does the current ROE for MediPal Holdings Corporation (MAHLY) compare to its historical average?